Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) treated with omalizumab: results of three randomized, double-blind, placebo-controlled clinical trials

被引：0
|
作者：
Spector, S. [1 ]
Antonova, E. [2 ]
Trzaskoma, B. [2 ]
Omachi, T. A. [2 ]
Zazzali, J. L. [2 ]
机构：
[1] Calif Allergy & Asthma Med Grp Inc, Los Angeles, CA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
来源：
ALLERGY | 2015年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
333
引用
收藏
页码：154 / 155
页数：2
相关论文
共 50 条
  • [11] Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): Two randomized, double-blind, placebo-controlled, phase 3 trials
    Maurer, Marcus
    Casale, Thomas B.
    Saini, Sarbjit S.
    Ben-Shoshan, Moshe
    Gimenez-Arnau, Ana M.
    Bernstein, Jonathan A.
    Yagami, Akiko
    Stjepanovic, Aleksandra
    Radin, Allen
    Staudinger, Heribert W.
    Patel, Naimish
    Amin, Nikhil
    Akinlade, Bolanle
    Fan, Chunpeng
    Bauer, Deborah
    Yancopoulos, George D.
    Patel, Kiran
    Mannent, Leda P.
    Laws, Elizabeth
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 154 (01) : 184 - 194
  • [12] Cyclosporine in chronic idiopathic urticaria: A double-blind, randomized, placebo-controlled trial
    Vena, Gino A.
    Cassano, Nicoletta
    Colombo, Delia
    Pcruzzi, Elena
    Pigatto, Paolo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (04) : 705 - 709
  • [13] Clinical Characteristics of Adolescent Patients with Refractory Chronic Idiopathic/Spontaneous Urticaria (CIU/CSU) in Three Phase III Studies with Omalizumab
    Goldstein, Stanley
    Skoner, David P.
    Ortiz, Benjamin
    Kianifard, Farid
    Vu, Julie
    Mendelson, Meryl
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (02) : AB129 - AB129
  • [14] Omalizumab normalizes gene expression in lesional skin of patients with chronic spontaneous urticaria: Results from a randomized, double-blind, placebo-controlled study
    Metz, Martin
    Torene, Rebecca
    Letzkus, Martin
    Hartmann, Nicole
    Staubach, Petra
    Bauer, Andrea
    Brehler, Randolf
    Ashton-Chess, Joanna
    Maurer, Marcus
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB64 - AB64
  • [15] The safety and efficacy of omalizumab in chronic idiopathic/spontaneous urticaria: results from a phase III randomised, double-blind, placebo-controlled study
    Maurer, M.
    Staubach, P.
    Ashby, M.
    Canvin, J.
    Ledford, D.
    Kaplan, A.
    Jakob, T.
    Rosen, K.
    ALLERGY, 2013, 68 : 704 - 704
  • [16] Omalizumab effectively reduces angioedema episodes in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 18 - 18
  • [17] Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients
    Jorg, L.
    Pecaric-Petkovic, T.
    Reichenbach, S.
    Coslovsky, M.
    Stalder, O.
    Pichler, W.
    Hausmann, O.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2018, 48 (02): : 196 - 204
  • [18] A Randomized, Double-Blind, Placebo-Controlled Clinical Trial Of Omalizumab For Chronic Rhinosinusitis
    Mehta, N. J.
    Pinto, J.
    de Tineo, M.
    Baroody, F. M.
    Naclerio, R. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S201 - S201
  • [19] The safety and efficacy of Omalizumab in chronic idiopathic/dpontaneous urticaria: Results from a phase iii randomized, double-blind, placebo-controlled study
    Katelaris, C. H.
    Maurer, M.
    Staubach, P.
    Ashby, M.
    Canvin, J.
    Ledford, D.
    Kaplan, A.
    Jakob, T.
    Rosen, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2014, 55 : 37 - 37
  • [20] Omalizumab reduced symptoms and improved health-related quality of life (HRQoL) in patients with refractory chronic spontaneous/idiopathic urticaria (CSU/CIU) in three randomized, double-blind, placebo-controlled phase III trials: a post-hoc analysis of percent change from baseline
    Casale, T.
    Maurer, M.
    Saini, S. S.
    Bernstein, J. A.
    Kaplan, A.
    Rosen, K.
    Li, J.
    Georgiou, P.
    Canvin, J.
    ALLERGY, 2014, 69 : 580 - 581
12345